New potential peptide therapeutics perturbing CK1δ/α-tubulin interaction
Marc Krüger1, Hubert Kalbacher2, Panagiotis L Kastritis3
1Department of General and Visceral Surgery, Ulm University Hospital, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
Abstract:
Members of the CK1 family are highly conserved serine/threonine specific kinases being expressed in all eukaryotes. They are involved in many cellular processes and therefore tightly regulated. A central mechanism to modulate CK1 activity is via interaction with cellular proteins. CK1δ interacts with α-/β-tubulin and is involved in the regulation of microtubule dynamics. Therefore, it is important to identify the structural elements responsible for the interaction between these proteins. Using a peptide library covering the human CK1δ amino acid sequence in SPR and ELISA analyses, we identified peptide 39 (P39), encompassing aa361-aa375 of CK1δ, as a prominent binding partner of α-tubulin. P39 decreases α-tubulin phosphorylation by CK1δ and reduces the thermodynamic stability of α-tubulin in fluorescence thermal shift assays. Furthermore, P39 induces an inhibition of mitotic progression and a disruption of cells entering mitosis in CV-1 cells. Taken together our data provide valuable information regarding the interaction of CK1δ and α-tubulin and a novel approach for the development of pharmacological tools to inhibit proliferation of cancer cells.
Insights
Researchers identified a specific peptide (P39) from casein kinase 1 delta (CK1δ) that binds to alpha-tubulin. This interaction inhibits cell division, offering potential for new cancer therapies.
Area of Science:
- Biochemistry
- Cell Biology
Background:
- Casein kinase 1 delta (CK1δ) is a serine/threonine kinase regulating cellular processes.
- CK1δ interacts with α-/β-tubulin, influencing microtubule dynamics.
- Understanding this interaction is crucial for modulating CK1δ activity.
Purpose of the Study:
- To identify structural elements mediating CK1δ and α-tubulin interaction.
- To investigate the functional consequences of this interaction.
Main Methods:
- Peptide library screening using Surface Plasmon Resonance (SPR) and ELISA.
- Fluorescence thermal shift assays to assess protein stability.
- Cell-based assays to observe effects on mitotic progression.
Main Results:
- Peptide 39 (P39) of CK1δ (aa361-aa375) was identified as a key α-tubulin binding partner.
- P39 reduced α-tubulin phosphorylation by CK1δ and decreased its thermodynamic stability.
- P39 treatment inhibited mitotic progression and disrupted cell entry into mitosis in CV-1 cells.
Conclusions:
- The study elucidates critical aspects of the CK1δ-α-tubulin interaction.
- P39 represents a novel molecular tool for targeting CK1δ-α-tubulin binding.
- Findings suggest a potential therapeutic strategy for inhibiting cancer cell proliferation.
